Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally adv ...

MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) ("LifeWallet," or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery ...

As Chinese entities do not have access to tens of thousands of advanced AI GPUs from companies like Nvidia, companies from ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

To stay competitive, some companies are scrambling to adopt AI, but they are sometimes unsure of the best way to integrate it ...

The latest version of the LLM had high concordance with a multidisciplinary heart team in choosing between PCI and CABG.

By contrast, ChatGPT 4.0 hit 100% accuracy for diagnostic testing and a 33% accuracy rate for surgical intervention ...

CHARLOTTESVILLE — With hospitals already deploying artificial intelligence to improve patient care, a new study has found ...

Debate on whether artificial intelligence's ROI matches its ambitious claims rages on. Is AI making an impact on the bottom ...